Morgan L. Maeder
- Aging top 0.2%
- Molecular Biology top 0.2%
- CRISPR and Genetic Engineering 31
- Advanced biosensing and bioanalysis techniques 16
- RNA Interference and Gene Delivery 13
- RNA and protein synthesis mechanisms 7
- Pluripotent Stem Cells Research 4
- Retinal Development and Disorders 4
- Genetics top 0.5%
- Virus-based gene therapy research 4
- Cell Biology top 1%
-
- Plant Virus Research Studies 5
- Co-authors
- J. Keith JoungYanfang FuJeffry D. SanderDeepak ReyonCyd KhayterRandall T. PetersonJing-Ruey Joanna YehShengdar Q. Tsai
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Morgan L. Maeder
41 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Business and International Management 866
- Aging 681
- Molecular Biology 10.3k
- Genetics 2.5k
- Cell Biology 816
Countries citing papers authored by Morgan L. Maeder
This map shows the geographic impact of Morgan L. Maeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. Maeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. Maeder more than expected).
Fields of papers citing papers by Morgan L. Maeder
This network shows the impact of papers produced by Morgan L. Maeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. Maeder. The network helps show where Morgan L. Maeder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Morgan L. Maeder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | Efficient in vivo editing of CEP290 IVS26 by EDIT-101 as a novel therapeutic for treatment of Leber Congenital Amaurosis 10 | 2018 | 2 |
| 3 | 2018 | 93 | |
| 4 | 2018 | 66 | |
| 5 | Genome-editing Technologies for Gene and Cell Therapybreakdown → | 2016 | 472 |
| 6 | 2015 | 223 | |
| 7 | 2015 | 9 | |
| 8 | Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivobreakdown → | 2014 | 1160 |
| 9 | 2013 | 278 | |
| 10 | High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsbreakdown → | 2013 | 2476 |
| 11 | CRISPR RNA–guided activation of endogenous human genesbreakdown → | 2013 | 926 |
| 12 | 2013 | 139 | |
| 13 | 2012 | 33 | |
| 14 | 2011 | 11 | |
| 15 | 2011 | 57 | |
| 16 | 2010 | 269 | |
| 17 | 2010 | 8 | |
| 18 | 2010 | 17 | |
| 19 | 2009 | 106 | |
| 20 | 2009 | 193 |
About Morgan L. Maeder
Morgan L. Maeder is a scholar working on Molecular Biology, Genetics and Sensory Systems, having authored 41 papers that have together received 11.4k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (31 papers), Advanced biosensing and bioanalysis techniques (16 papers), RNA Interference and Gene Delivery (13 papers), RNA and protein synthesis mechanisms (7 papers), Plant Virus Research Studies (5 papers), Virus-based gene therapy research (4 papers), Pluripotent Stem Cells Research (4 papers) and Retinal Development and Disorders (4 papers). The work is most often cited by research in Business and International Management (866 citations), Aging (681 citations) and Molecular Biology (10.3k citations). Morgan L. Maeder has collaborated with scholars based in United States, Germany and France. Frequent co-authors include J. Keith Joung, Yanfang Fu, Jeffry D. Sander, Deepak Reyon, Cyd Khayter, Randall T. Peterson, Jing-Ruey Joanna Yeh, Shengdar Q. Tsai, Woong Y. Hwang and Charles A. Gersbach. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.